Cargando…
Cis-acting lnc-eRNA SEELA directly binds histone H4 to promote histone recognition and leukemia progression
BACKGROUND: Long noncoding enhancer RNAs (lnc-eRNAs) are a subset of stable eRNAs identified from annotated lncRNAs. They might act as enhancer activity-related therapeutic targets in cancer. However, the underlying mechanism of epigenetic activation and their function in cancer initiation and progr...
Autores principales: | Fang, Ke, Huang, Wei, Sun, Yu-Meng, Chen, Tian-Qi, Zeng, Zhan-Cheng, Yang, Qian-Qian, Pan, Qi, Han, Cai, Sun, Lin-Yu, Luo, Xue-Qun, Wang, Wen-Tao, Chen, Yue-Qin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7607629/ https://www.ncbi.nlm.nih.gov/pubmed/33143730 http://dx.doi.org/10.1186/s13059-020-02186-x |
Ejemplares similares
-
eRNAs and Superenhancer lncRNAs Are Functional in Human Prostate Cancer
por: Zhang, Xiaona, et al.
Publicado: (2020) -
The lncRNA LAMP5-AS1 drives leukemia cell stemness by directly modulating DOT1L methyltransferase activity in MLL leukemia
por: Wang, Wen-Tao, et al.
Publicado: (2020) -
Correction to: The lncRNA LAMP5-AS1 drives leukemia cell stemness by directly modulating DOT1L methyltransferase activity in MLL leukemia
por: Wang, Wen-Tao, et al.
Publicado: (2021) -
Exploring the potential of eRNAs in cancer immunotherapy
por: Luo, Lianxiang, et al.
Publicado: (2022) -
The snoRNA-like lncRNA LNC-SNO49AB drives leukemia by activating the RNA-editing enzyme ADAR1
por: Huang, Wei, et al.
Publicado: (2022)